1. Home
  2. CHCT vs CRGX Comparison

CHCT vs CRGX Comparison

Compare CHCT & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHCT
  • CRGX
  • Stock Information
  • Founded
  • CHCT 2014
  • CRGX 2021
  • Country
  • CHCT United States
  • CRGX United States
  • Employees
  • CHCT 37
  • CRGX N/A
  • Industry
  • CHCT Real Estate Investment Trusts
  • CRGX
  • Sector
  • CHCT Real Estate
  • CRGX
  • Exchange
  • CHCT Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • CHCT 559.3M
  • CRGX 621.4M
  • IPO Year
  • CHCT 2015
  • CRGX 2023
  • Fundamental
  • Price
  • CHCT $20.18
  • CRGX $12.86
  • Analyst Decision
  • CHCT Buy
  • CRGX Strong Buy
  • Analyst Count
  • CHCT 4
  • CRGX 6
  • Target Price
  • CHCT $21.25
  • CRGX $31.80
  • AVG Volume (30 Days)
  • CHCT 266.0K
  • CRGX 279.0K
  • Earning Date
  • CHCT 02-11-2025
  • CRGX 11-12-2024
  • Dividend Yield
  • CHCT 9.30%
  • CRGX N/A
  • EPS Growth
  • CHCT N/A
  • CRGX N/A
  • EPS
  • CHCT N/A
  • CRGX N/A
  • Revenue
  • CHCT $115,612,000.00
  • CRGX N/A
  • Revenue This Year
  • CHCT N/A
  • CRGX N/A
  • Revenue Next Year
  • CHCT $7.55
  • CRGX N/A
  • P/E Ratio
  • CHCT N/A
  • CRGX N/A
  • Revenue Growth
  • CHCT 6.00
  • CRGX N/A
  • 52 Week Low
  • CHCT $15.06
  • CRGX $10.91
  • 52 Week High
  • CHCT $28.10
  • CRGX $33.92
  • Technical
  • Relative Strength Index (RSI)
  • CHCT 64.82
  • CRGX 42.73
  • Support Level
  • CHCT $18.45
  • CRGX $10.91
  • Resistance Level
  • CHCT $19.23
  • CRGX $15.75
  • Average True Range (ATR)
  • CHCT 0.56
  • CRGX 1.16
  • MACD
  • CHCT 0.11
  • CRGX -0.03
  • Stochastic Oscillator
  • CHCT 97.22
  • CRGX 39.63

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Share on Social Networks: